Anthem Biosciences Limited (NSE:ANTHEM)
754.00
-1.60 (-0.21%)
Jun 3, 2026, 11:51 AM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 424.35 billion as of June 2, 2026.
Market Cap
424.35B
Enterprise Value
415.50B
Revenue
21.24B
Ranking
n/a
PE Ratio
72.44
Stock Price
754.00
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 424.35B, an increase of 3.46%. That is a compound annual growth rate of 4.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 423.48B | 15.74% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 688.86B |
| OneSource Specialty Pharma | 210.69B |
| Concord Biotech | 111.03B |
| Supriya Lifescience | 84.71B |
| Blue Jet Healthcare | 77.48B |
| Zota Health Care | 38.97B |
| Dishman Carbogen Amcis | 30.67B |
| Panacea Biotec | 24.38B |